secwatch.observer — SEC 8-K summary
======================================

Issuer:     THERAPEUTIC SOLUTIONS INTERNATIONAL, INC. (—)
CIK:        0001419051
Form:       8-K
Filed at:   2024-02-21T23:59:59+00:00
Accession:  0001493152-24-007443
Event type: other
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.03, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Therapeutic Solutions increases authorized shares from 5.5B to 6.5B via shareholder written consent
--------------------------------------------------------------------------------

- Certificate of Amendment filed Feb 20, 2024 raising authorized common stock from 5.5B to 6.5B shares.
- Approved by majority written consent of shareholders on Feb 19, 2024.
- Series A Preferred holder (Timothy G. Dixon, Thomas E. Ichim) retains effective voting control of the corporation.
- Authorized preferred stock remains unchanged at 5M shares.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1419051/000149315224007443/0001493152-24-007443-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1419051/000149315224007443/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-007443

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer